New therapeutic strategies for cell-mediated autoimmune diseases
Goldman, M.
Acta Neurologica Belgica 94(2): 89-91
1994
ISSN/ISBN: 0300-9009 PMID: 7913569 Document Number: 432653
Document emailed within 1 workday
Related Documents
Eto, S.; Fujihira, T. 1988: Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and the therapeutic methods. Organ-specific autoimmune diseases. 1) Autoimmune thyroid diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 894-900Fukase, M. 1975: Cell-mediated immunity in autoimmune diseases Rinsho Byori. Japanese Journal of Clinical Pathology 23(1): 40-46
Nagasawa, T. 1988: Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and the therapeutic methods. Organ-specific autoimmune diseases. 5) Anti-GBM antibody diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 918-924
Azuma, T. 1988: Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 4) Rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 883-887
Guerra, F.; Bellido, C.; Aguilar, R.; Jurado, R.; Garrido, F.; Sánchez Guijo, P. 1981: Inhibition of antibody-dependent cell-mediated cytotoxicity (CIA) as a technic for measuring circulating immune complexes in autoimmune diseases Revista Clinica Espanola 163(6): 397-402
Rosato, E.; Pisarri, S.; Salsano, F. 2010: Current strategies for the treatment of autoimmune diseases Journal of Biological Regulators and Homeostatic Agents 24(3): 251-259
Lou, Y-Huan. 2004: Anti-GBM glomerulonephritis: a T cell-mediated autoimmune disease? Archivum Immunologiae et Therapiae Experimentalis 52(2): 96-103
Ndiaye, M.R.; Sarr, M.H.; Ba, E.A.; Ndoye, P.A.; Seye-Ndiaye, C.; Ndiaye, P.A.; Wade, P.A. 1996: Corneal marginal ulcer. Autoimmune diseases, new therapeutic aspects Dakar Medical Spec No: 35-37
Fujitani, Y. 2013: Strategy for research development of therapeutic agents for autoimmune diseases Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 57
Boitard, C.; Chatenoud, L.M.; Debray-Sachs, M. 1982: In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon Journal of Immunology 129(6): 2529-2531
Diehl, L.F.; Ketchum, L.H. 1998: Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia Seminars in Oncology 25(1): 80-97
Hoover, M.L.; Capra, J.D. 1987: The T cell receptor and autoimmune diseases Molecular Biology and Medicine 4(3): 123-132
Katsuki, H.; Kaneko, S. 2014: New therapeutic strategies for cerebrovascular diseases based on the control of intra-cerebral inflammation Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 144(3): 103
Thiele, K.P. 1997: Prognostic factors and therapeutic strategies in small cell bronchial carcinoma Praxis 86(42): 1660-1667
Tsubata, T. 1997: Mechanisms for B cell tolerance and their defects in systemic autoimmune diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 55(6): 1351-1355
Wang, Z-hui.; Liao, Y-hua.; Yuan, J.; Zhang, L.; Wang, M.; Zhang, J-hui.; Liu, Z-ping.; Dong, J-hua. 2007: A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy Chinese Medical Journal 120(15): 1319-1325
Bradley, T.P.; Bonavida, B. 1982: Mechanism of cell-mediated cytotoxicity at the single cell level. V. the importance of target cell structure in cytotoxic T lymphocyte-mediated antigen nonspecific lectin-dependent cellular cytotoxicity Journal of Immunology 129(6): 2352-2356
Oyama, Y. 2003: Autologous and allogeneic stem cell transplantation for severe autoimmune diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 61(9): 1643-1654
Bradley, T.P.; Bonavida, B. 1982: Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay Journal of Immunology 129(5): 2260-2265
Messner, R.P. 1997: The potential of bone marrow stem cell transplantation in the treatment of autoimmune diseases Journal of Rheumatology 24(5): 819-821